kidney cross section Researchers assessed the incidence and potential risk factors for the development of fenofibrate-associated nephrotoxicity in patients with gout. Fenofibrate-associated ...
ORLANDO, Fla. — The old, generic cholesterol drug fenofibrate has shown potential for slowing the progression of diabetic retinopathy in people with early retinal changes, with the potential to reduce ...
Objective Diabetic patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] 30–59 mL/min/1.73 m 2) are at particular cardiovascular risk. Fenofibrate's safety in these ...
Co and AstraZeneca confirmed they will advance the development of ABT's next-generation fenofibrate ABT-335 and AstraZeneca's Crestor in a fixed-dose combination treatment into Phase III clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results